Short answer
MEDIFAST INC (MED) filed an 8-K current report with the SEC on October 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 FY2026 earnings release issued October 26, 2026.
MEDIFAST INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 FY2026 earnings release issued October 26, 2026
- Reporting period ended September 30, 2026
- Detailed financial results contained in Exhibit 99.1 press release
- Disclosure furnished under Regulation FD, not deemed filed under Exchange Act Section 18
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $72.0M, down 19.4% YoY, as active earning coaches fell 47.7% to 10,200
- Coach productivity improved 54.1% to $7,064, but management expects coach declines through year-end 2026
- GAAP net loss $17.5M, or $1.57 per diluted share, including $15.4M of Catalyst restructuring charges
- Adjusted net loss $2.1M, or $0.19 per diluted share, with adjusted EBITDA excluding interest income of $1.9M
- Q4 revenue outlook $55M-$75M and EPS $0.00-$0.25, while full-year revenue guidance remains $280M-$300M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MEDIFAST INC 8-K filings
Get the next MED 8-K as it lands
Follow MED for push alerts, or ask the research agent what this filing means.